Table 5.
Antimicrobial resistance and comparison between biofilm formers and non-formers, Com-UTI and CA-UTI
| Antimicrobial agents | Class of antimicrobial agents | Resistance expressed inpercentage (%) | P-value | Resistance expressed in percentage (%) | P-value | ||
|---|---|---|---|---|---|---|---|
| Biofilm-former | Biofilm non-former | Com-UTI | CA-UTI | ||||
| Amikacin | Aminoglycosides | 50 | 27 | 0.001 | 31 | 54 | 0.001 |
| Gentamicin | Aminoglycosides | 54 | 12 | 0.0001 | 20 | 60 | 0.0001 |
| Cephalexin | Cephalosporins | 54 | 10 | 0.0001 | 17 | 52 | 0.0001 |
| Ceftriaxone | Cephalosporins | 53 | 3 | 0.0001 | 12 | 50 | 0.0001 |
| Ofloxacin | Fluoroquinolones | 34 | 19 | 0.001 | 19 | 51 | 0.0001 |
| Co-trimoxazole | Folic acid synthesis inhibitors | 23 | 7 | 0.0001 | 7 | 38 | 0.0001 |
| Nitrofurantoin | Nitrofurans | 36 | 4 | 0.0001 | 11 | 25 | 0.05 |
| Penicillin | Penicillins | 57 | 56 | 0.419 | 52 | 80 | 0.0001 |
| Vancomycin | Glycopeptides | 10 | 1 | 0.0001 | 2 | 11 | 0.0001 |
| Linezolid | Oxazolidonones | 0 | 0 | NA | 0 | 0 | NA |
Abbreviation: CA-UTI , catheter-associated urinary tract infection; Com-UTI, community-acquired urinary tract infection; NA, not applicable.